106 related articles for article (PubMed ID: 27263157)
1. [Not Available].
Nau JY
Rev Med Suisse; 2016 Apr; 12(514):766-7. PubMed ID: 27263157
[No Abstract] [Full Text] [Related]
2. [A new method in biotechnology].
Hofmann-Aßmus M
MMW Fortschr Med; 2015 Apr; 157(7):75. PubMed ID: 26012467
[No Abstract] [Full Text] [Related]
3. Editing and investigating genomes with TALE and CRISPR/Cas systems: applications of artificial TALE and CRISPR-Cas systems.
Giovannangeli C; Concordet JP
Methods; 2014 Sep; 69(2):119-20. PubMed ID: 25248487
[No Abstract] [Full Text] [Related]
4. Assembling the Streptococcus thermophilus clustered regularly interspaced short palindromic repeats (CRISPR) array for multiplex DNA targeting.
Guo L; Xu K; Liu Z; Zhang C; Xin Y; Zhang Z
Anal Biochem; 2015 Jun; 478():131-3. PubMed ID: 25748774
[TBL] [Abstract][Full Text] [Related]
5. [The affair "Crispr-Cas9" or genetically enhanced humanity].
Nau JY
Rev Med Suisse; 2014 Jun; 10(436):1428-9. PubMed ID: 25055481
[No Abstract] [Full Text] [Related]
6. Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats.
Mashimo T
Dev Growth Differ; 2014 Jan; 56(1):46-52. PubMed ID: 24372523
[TBL] [Abstract][Full Text] [Related]
7. Harnessing CRISPR-Cas systems for bacterial genome editing.
Selle K; Barrangou R
Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
[TBL] [Abstract][Full Text] [Related]
8. [Not Available].
Nau JY
Rev Med Suisse; 2016 Mar; 12(512):666-7. PubMed ID: 27172698
[No Abstract] [Full Text] [Related]
9. Targeted mutagenesis in Zea mays using TALENs and the CRISPR/Cas system.
Liang Z; Zhang K; Chen K; Gao C
J Genet Genomics; 2014 Feb; 41(2):63-8. PubMed ID: 24576457
[TBL] [Abstract][Full Text] [Related]
10. CRISPR adaptation in Escherichia coli subtypeI-E system.
Kiro R; Goren MG; Yosef I; Qimron U
Biochem Soc Trans; 2013 Dec; 41(6):1412-5. PubMed ID: 24256229
[TBL] [Abstract][Full Text] [Related]
11. Plant genome engineering in full bloom.
Lozano-Juste J; Cutler SR
Trends Plant Sci; 2014 May; 19(5):284-7. PubMed ID: 24674878
[TBL] [Abstract][Full Text] [Related]
12. Delivery and Specificity of CRISPR-Cas9 Genome Editing Technologies for Human Gene Therapy.
Gori JL; Hsu PD; Maeder ML; Shen S; Welstead GG; Bumcrot D
Hum Gene Ther; 2015 Jul; 26(7):443-51. PubMed ID: 26068008
[TBL] [Abstract][Full Text] [Related]
13. Weakly immunogenic CRISPR therapies.
Wilson EA; Anderson KS
Nat Biomed Eng; 2019 Oct; 3(10):761-762. PubMed ID: 31591524
[No Abstract] [Full Text] [Related]
14. Ji Luo Elucidates the CRISPR Gene Editing Technology, and How It May Affect Cancer Therapy in the Future.
Luo J
Oncology (Williston Park); 2016 Oct; 30(10):879. PubMed ID: 27753053
[No Abstract] [Full Text] [Related]
15. [The revolution of the CRISPR is underway].
Gilgenkrantz H
Med Sci (Paris); 2014 Dec; 30(12):1066-9. PubMed ID: 25537031
[No Abstract] [Full Text] [Related]
16. The Future of Genome Editing.
Cell; 2018 May; 173(6):1311-1313. PubMed ID: 29856947
[TBL] [Abstract][Full Text] [Related]
17. Selection and Validation of Spacer Sequences for CRISPR-Cas9 Genome Editing and Transcription Regulation in Bacteria.
Grenier F; Lucier JF; Rodrigue S
Methods Mol Biol; 2015; 1334():233-44. PubMed ID: 26404154
[TBL] [Abstract][Full Text] [Related]
18. Making the cut.
Travis J
Science; 2015 Dec; 350(6267):1456-7. PubMed ID: 26680172
[No Abstract] [Full Text] [Related]
19. [The CRISPR system can correct or modify the expression of genes responsible for hereditary diseases].
Tremblay JP
Med Sci (Paris); 2015 Nov; 31(11):1014-22. PubMed ID: 26576609
[TBL] [Abstract][Full Text] [Related]
20. Computational Detection of CRISPR/crRNA Targets.
Biswas A; Fineran PC; Brown CM
Methods Mol Biol; 2015; 1311():77-89. PubMed ID: 25981467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
